Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
In Vivo (Athens, Greece)|February 27, 2019
Primary Mediastinal HER2-positive Apocrine Carcinoma in Mature Teratoma Treated With Anti-HER2 Therapy and ChemoradiationKeiji Sugiyama, Akari Iwakoshi, Mariko Satoh, et al.
The Lancet. Oncology|January 13, 2009
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trialMitsue Saito, Kenjiro Aogi, Ikuo Sekine, et al.
The Tohoku Journal of Experimental Medicine|October 14, 2021
The Role of Rigid Bronchoscopic Intervention for Bronchial CarcinoidAtsushi Torii, Masahide Oki, Yurika Ishii, et al.
BMC Cancer|July 15, 2022
Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancerYoshiya Matsumoto, Tomoya Kawaguchi, Masaru Watanabe, et al.
In Vivo (Athens, Greece)|December 28, 2018
Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung CancerChiyoe Kitagawa, Masahiro Iwasaku, Yoshihito Kogure, et al.
Respiratory Medicine Case Reports|April 29, 2024
A case of community-acquired Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus (MRSA) necrotizing pneumonia successfully treated with two anti-MRSA drugsRitsuya Shiiba, Masahiro Sano, Yoshihito Kogure, et al.
BMC Cancer|November 8, 2022
Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomesKoichi Sato, Hiroaki Akamatsu, Yasuhiro Koh, et al.
Investigational New Drugs|January 11, 2017
Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I studyHideo Saka, Chiyoe Kitagawa, Yoshihito Kogure, et al.
Japanese Journal of Clinical Oncology|March 13, 2018
Sterilized talc pleurodesis for malignant pleural effusions: a Phase II study for investigational new drug application in JapanHideo Saka, Masahide Oki, Chiyoe Kitagawa, et al.
Respiratory Investigation|January 24, 2024
Talc slurry pleurodesis in patients with secondary intractable pneumothorax: A phase 2 studyHideo Saka, Masahide Oki, Yoshikane Yamauchi, et al.
Pageof 7